BSX vs XLO · P/E 20, rev $10.65B vs rev $31.3M
Boston Scientific Corp (BSX) versus Xilio Development Inc (XLO) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
Xilio Development Inc (XLO) is a biotechnology company listed on NASDAQ.
Latest reported BSX revenue for 2026-06-30 was $10.65B. Net income was $2.24B. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Latest reported XLO revenue for 2026-06-30 was $31.3M. Net income was -$15.9M. XLO currently screens at market cap $55.3M.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. XLO currently screens at market cap $55.3M.
Not investment advice. Open the BSX and XLO stock pages for the full models.
Not investment advice.